References
- UNAIDS. UNAIDS report on the global AIDS epidemic 2013.
Geneva: www.UNAIDS.org; 2013. Visité le 25 Avril 2016. Google
Scholar
- OMS. Vers un accès universel. Étendre les interventions
prioritaires liées au VIH/SIDA dans le secteur de la santé. Rapport de
situation 2008. Geneva: http://www.who.int/hiv/pub/towards_universal_access_report_2008_fr.pdf;
2008. Visité le 25 Avril 2016. Google
Scholar
- Caron M, Lekana-Douki SE, Makuwa M, Obiang-Ndong GP, Biba O, Nkoghe D et al. Prevalence, genetic diversity and antiretroviral drugs resistance-associated mutations among untreated HIV-1-infected pregnant women in Gabon, central Africa. BMC infectious diseases. 2012;12:64. PubMed | Google Scholar
- Mombo LE, Bisseye C, Mickala P, Ossari S, Makuwa M. Genotyping of CCR5 gene, CCR2b and SDF1 variants related to HIV-1 infection in Gabonese subjects. Intervirology. 2015;58(1):22-6. PubMed | Google Scholar
- PNL-IST-VIH/SIDA. Guide de prise en charge des personnes vivant avec le VIH et le SIDA au Gabon. Libreville: Ministère de la Santé, Édition 2014; 2014. Google Scholar
- OMS. Antiretroviral therapy for HIV infection in
adults and adolescents. Geneva: http://www.who.int/hiv/pub/guidelines/adult/en/;
200 Visité le 25 Avril 2016. Google
Scholar
- OMS. Antiretroviral therapy for HIV infection in
adults and adolescents. Geneva: http://www.who.int/hiv/pub/arv/adult2010/en/;
2010. Google
Scholar
- OMS. Consolidated guidelines on the use of antiretroviral
drugs for treating and preventing HIV infection. Geneva:
http://apps.who.int/iris/bitstream/10665/85321/1/9789241505727_eng.pdf;
2013. Visité le 25 Avril 2016. Google
Scholar
- Okome Nkoumou MML, Okome Essima R, Obiang Ndong GP, Okome Miame F. Bilan clinico-biologique des patients infectés par le VIH à la fondation jeanne EBORI de Libreville (2002-2005). Med Trop. 2007; 67(4):357-62. PubMed | Google Scholar
- Moore DM, Yiannoutsos CT, Musick BS, Tappero J, Degerman R, Campbell J et al. Determinants of early and late mortality among HIV-infected individuals receiving home-based antiretroviral therapy in rural Uganda. Journal of acquired immune deficiency syndromes. 2011;58(3):289-96. PubMed | Google Scholar
- Bekolo CE, Webster J, Batenganya M, Sume GE, Kollo B. Trends in mortality and loss to follow-up in HIV care at the Nkongsamba Regional hospital, Cameroon. BMC research notes. 2013;6:512. PubMed | Google Scholar
- Kone MC, Cissoko Y, Diallo MS, Traore BA, Malle KK. [Epidemiological, clinical and therapeutics' data of HIV-infected patients placed on ART in the Segou hospital in Mali (2004-2011)]. Bulletin de la Societe de pathologie exotique. 2013;106(3):176-9. PubMed | Google Scholar
- Aliyu MH, Blevins M, Parrish DD, Megazzini KM, Gebi UI, Muhammad MY et al. Risk factors for delayed initiation of combination antiretroviral therapy in rural north central Nigeria. Journal of acquired immune deficiency syndromes. 2014;65(2):e41-9. PubMed | Google Scholar
- Caron M, Makuwa M, Souquière S, Descamps D, Brun-Vézinet F, Kazanji M. Human immunodeficiency virus type 1 seroprevalence and antiretroviral drug resistance-associated mutations in miners in Gabon, central Africa. AIDS Res Hum Retroviruses. 2008 Sep;24(9):1225-8. PubMed | Google Scholar
- Bashi J, Balestre E, Messou E, Maiga M, Coffie PA, Zannou DM et al. [Time trends in demographic and clinical characteristics of adult patients on HAART initiation in West Africa]. Medecine et maladies infectieuses. 2010;40(8):449-55. PubMed | Google Scholar
- Braitstein P, Brinkhof MW, Dabis F, Schechter M, Boulle A, Miotti P et al. Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. Lancet. 2006;367(9513):817-24. PubMed | Google Scholar
- Calmy A, Pinoges L, Szumilin E, Zachariah R, Ford N, Ferradini L et al. Generic fixed-dose combination antiretroviral treatment in resource-poor settings: multicentric observational cohort. Aids. 2006;20(8):1163-9. PubMed | Google Scholar
- Sieleunou I, Souleymanou M, Schonenberger AM, Menten J, Boelaert M. Determinants of survival in AIDS patients on antiretroviral therapy in a rural centre in the Far-North Province, Cameroon. Tropical medicine& international health, TM & IH. 2009;14(1):36-43. PubMed | Google Scholar
- Rosen S, Fox MP, Gill CJ. Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review. PLoS medicine. 2007;4(10):e298. PubMed | Google Scholar
- Egger M, Spycher BD, Sidle J, Weigel R, Geng EH, Fox MP et al. Correcting mortality for loss to follow-up: a nomogram applied to antiretroviral treatment programmes in sub-Saharan Africa. PLoS medicine. 2011;8(1):e1000390. PubMed | Google Scholar
- Fox MP, Shearer K, Maskew M, Macleod W, Majuba P, Macphail P et al. Treatment out comes after 7 years of public-sector HIV treatment. Aids. 2012;26(14):1823-8. PubMed | Google Scholar
- Marazzi MC, Liotta G, Germano P, Guidotti G, Altan AD, Ceffa S et al. Excessive earlymortality in the first year of treatment in HIV type 1-infected patients initiating antiretroviral therapy in resource-limited settings. AIDS research and human retroviruses. 2008;24(4):555-60. PubMed | Google Scholar
- Cornell M, Schomaker M, Garone DB, Giddy J, Hoffmann CJ, Lessells R et al. Gender differences in survival among adult patients starting antiretroviral therapy in South Africa: a multicenter cohort study. PLoS medicine. 2012;9(9):e1001304. PubMed | Google Scholar